Food and Drug
Drugs Advisory Committee
March 6, 2006
contained in this document(s) are those of the product's sponsor,
not FDA, and FDA does not necessarily agree with the sponsor's
statements. FDA has not made a final determination about the
safety or effectiveness of the product described in this document.
CubicinŽ (daptomycin for injection)
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the
FOIA) (5 U.S.C. §552).
These redacted portions will appear as white space on the
screen or on the printed page.
FDA Backgrounder on CubicinŽ
FDA Backgrounder Errata
FDA Backgrounder Errata 2